The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCormick, J. K.
Right arrow Articles by Schlievert, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCormick, J. K.
Right arrow Articles by Schlievert, P. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 00, 165: 2306-2312.
Copyright © 00 by The American Association of Immunologists

Development of Streptococcal Pyrogenic Exotoxin C Vaccine Toxoids That Are Protective in the Rabbit Model of Toxic Shock Syndrome1

John K. McCormick*, Timothy J. Tripp*, Stephen B. Olmsted{ddagger}, Yury V. Matsuka{ddagger}, Pamala J. Gahr*, Douglas H. Ohlendorf{dagger} and Patrick M. Schlievert2,*

Departments of * Microbiology and {dagger} Biochemistry, University of Minnesota Medical School, Minneapolis, MN 55455; and {ddagger} Wyeth Vaccines, West Henrietta, NY 14586.

Streptococcal pyrogenic exotoxin C (SPE C) is a superantigen produced by many strains of Streptococcus pyogenes that (along with streptococcal pyrogenic exotoxin A) is highly associated with streptococcal toxic shock syndrome (STSS) and other invasive streptococcal diseases. Based on the three-dimensional structure of SPE C, solvent-exposed residues predicted to be important for binding to the TCR or the MHC class II molecule, or important for dimerization, were generated. Based on decreased mitogenic activity of various single-site mutants, the double-site mutant Y15A/N38D and the triple-site mutant Y15A/H35A/N38D were constructed and analyzed for superantigenicity, toxicity (lethality), immunogenicity, and the ability to protect against wild-type SPE C-induced STSS. The Y15A/N38D and Y15A/H35A/N38D mutants were nonmitogenic for rabbit splenocytes and human PBMCs and nonlethal in two rabbit models of STSS, yet both mutants were highly immunogenic. Animals vaccinated with the Y15A/N38D or Y15A/H35A/N38D toxoids were protected from challenge with wild-type SPE C. Collectively, these data indicate that the Y15A/N38D and Y15A/H35A/N38D mutants may be useful as toxoid vaccine candidates.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
M. Liu, H. Zhu, J. Zhang, and B. Lei
Active and Passive Immunizations with the Streptococcal Esterase Sse Protect Mice against Subcutaneous Infection with Group A Streptococci
Infect. Immun., July 1, 2007; 75(7): 3651 - 3657.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. K. M. N.-u. Rahman, C. A. Herfst, B. Moza, S. R. Shames, L. A. Chau, C. Bueno, J. Madrenas, E. J. Sundberg, and J. K. McCormick
Molecular Basis of TCR Selectivity, Cross-Reactivity, and Allelic Discrimination by a Bacterial Superantigen: Integrative Functional and Energetic Mapping of the SpeC-Vbeta2.1 Molecular Interface
J. Immunol., December 15, 2006; 177(12): 8595 - 8603.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. S. Courtney, D. L. Hasty, and J. B. Dale
Serum Opacity Factor (SOF) of Streptococcus pyogenes Evokes Antibodies That Opsonize Homologous and Heterologous SOF-Positive Serotypes of Group A Streptococci
Infect. Immun., September 1, 2003; 71(9): 5097 - 5103.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. J. Tripp, J. K. McCormick, J. M. Webb, and P. M. Schlievert
The Zinc-Dependent Major Histocompatibility Complex Class II Binding Site of Streptococcal Pyrogenic Exotoxin C Is Critical for Maximal Superantigen Function and Toxic Activity
Infect. Immun., March 1, 2003; 71(3): 1548 - 1550.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. M. Smoot, J. K. McCormick, J. C. Smoot, N. P. Hoe, I. Strickland, R. L. Cole, K. D. Barbian, C. A. Earhart, D. H. Ohlendorf, L. G. Veasy, et al.
Characterization of Two Novel Pyrogenic Toxin Superantigens Made by an Acute Rheumatic Fever Clone of Streptococcus pyogenes Associated with Multiple Disease Outbreaks
Infect. Immun., December 1, 2002; 70(12): 7095 - 7104.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. B. Beres, G. L. Sylva, K. D. Barbian, B. Lei, J. S. Hoff, N. D. Mammarella, M.-Y. Liu, J. C. Smoot, S. F. Porcella, L. D. Parkins, et al.
Genome sequence of a serotype M3 strain of group A Streptococcus: Phage-encoded toxins, the high-virulence phenotype, and clone emergence
PNAS, July 23, 2002; 99(15): 10078 - 10083.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. U. Kazmi, R. Kansal, R. K. Aziz, M. Hooshdaran, A. Norrby-Teglund, D. E. Low, A.-B. Halim, and M. Kotb
Reciprocal, Temporal Expression of SpeA and SpeB by Invasive M1T1 Group A Streptococcal Isolates In Vivo
Infect. Immun., August 1, 2001; 69(8): 4988 - 4995.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. D. Reid, N. M. Green, J. K. Buss, B. Lei, and J. M. Musser
Multilocus analysis of extracellular putative virulence proteins made by group A Streptococcus: Population genetics, human serologic response, and gene transcription
PNAS, June 19, 2001; 98(13): 7552 - 7557.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. K. McCormick, A. A. Pragman, J. C. Stolpa, D. Y. M. Leung, and P. M. Schlievert
Functional Characterization of Streptococcal Pyrogenic Exotoxin J, a Novel Superantigen
Infect. Immun., March 1, 2001; 69(3): 1381 - 1388.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.